Myriad Genetics, Inc.MYGNNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank93
3Y CAGR+38.0%
5Y CAGR+5.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+38.0%/yr
vs -11.6%/yr prior
5Y CAGR
+5.0%/yr
Recent acceleration
Acceleration
+49.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $149.60M | +46.1% |
| 2024 | $102.40M | -22.5% |
| 2023 | $132.10M | +132.2% |
| 2022 | $56.90M | -78.0% |
| 2021 | $258.40M | +120.9% |
| 2020 | $117.00M | +25.5% |
| 2019 | $93.20M | 0.0% |
| 2018 | $93.20M | -16.0% |
| 2017 | $110.90M | +8.3% |
| 2016 | $102.40M | - |